NDC 65193-340

Red Label Ephed Plus

Ephedrine Hydrochloride, Guaifenesin

Red Label Ephed Plus is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Dickey Consumer Products Dba Dmd. The primary component is Ephedrine Hydrochloride; Guaifenesin.

Product ID65193-340_44abfba6-be11-4b52-8007-bdbf8fbb872d
NDC65193-340
Product TypeHuman Otc Drug
Proprietary NameRed Label Ephed Plus
Generic NameEphedrine Hydrochloride, Guaifenesin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-03-15
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart341
Labeler NameDickey Consumer Products DBA DMD
Substance NameEPHEDRINE HYDROCHLORIDE; GUAIFENESIN
Active Ingredient Strength13 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 65193-340-24

24 TABLET in 1 BLISTER PACK (65193-340-24)
Marketing Start Date2019-03-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65193-340-48 [65193034048]

Red Label Ephed Plus TABLET
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-03-20

NDC 65193-340-24 [65193034024]

Red Label Ephed Plus TABLET
Marketing CategoryOTC monograph final
Application Numberpart341
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-03-20

Drug Details

Active Ingredients

IngredientStrength
EPHEDRINE HYDROCHLORIDE12.5 mg/1

OpenFDA Data

SPL SET ID:a79609d2-f125-40a8-ac86-0ad98589b0fb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1115991
  • UPC Code
  • 0098443240978
  • NDC Crossover Matching brand name "Red Label Ephed Plus" or generic name "Ephedrine Hydrochloride, Guaifenesin"

    NDCBrand NameGeneric Name
    65193-340Red Label Ephed Plusephedrine hydrochloride, guaifenesin
    65193-320Ephed Asthmaephedrine hydrochloride, guaifenesin
    65193-225Ephed Plusephedrine hydrochloride, guaifenesin
    65193-125Red Label Ephedrine Plusephedrine hydrochloride, guaifenesin
    70258-320VASOPRO EPHEDRINEEPHEDRINE HYDROCHLORIDE, GUAIFENESIN

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.